Follow Us
© 2026 Arizent. All rights reserved.
Eli Lilly is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up with rival Novo Nordisk A/S.
As of Monday, the lowest dose vial will cost $299 a month for those who pay cash, Lilly said in a statement, a discount of about $50. The next higher dose will cost $399 a month, roughly 20% less than the previous self-pay price. Lilly is also slashing the cost of higher doses by about $50.
For reprint and licensing requests for this article, click here.
Less expensive options and customized levels of support can help employers make these medications work within their benefits plan.
As healthcare costs climb, more large employers are contracting directly with hospitals and health systems to work out prices, improve quality and steer care.
With health benefit costs expected to rise 8.2% in 2027, employers are looking for ways to control spending without simply shifting more costs to workers.
MetLife’s president of U.S. business shares why improving employees’ benefits literacy results in them making smarter choices for their health and financial wellness.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
